Back
Deciphera Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
DCPH
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
25
DCPH
Deciphera Pharmaceuticals
Last Price:
14.66
Seasonality Move:
6.77%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.Deciphera Pharmaceuticals Price Quote
$14.66
+0.01 (+3.39%)
(Updated: April 27, 2024 at 6:01 AM ET)
Deciphera Pharmaceuticals Key Stats
Sell
25
Deciphera Pharmaceuticals (DCPH)
is a Sell
Day range:
$14.09 - $14.84
52-week range:
$9.90 - $17.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.63
P/B ratio:
3.37%
Volume:
329.8K
Avg. volume:
507K
1-year change:
1.81%
Market cap:
$1.2B
Revenue:
$163.4M
EPS:
$-2.29
How Much Does Deciphera Pharmaceuticals Make?
-
How Much Are Deciphera Pharmaceuticals's Sales Annually?
DCPH Revenues are $163.4M -
How Much Profit Does Deciphera Pharmaceuticals's Make A Year?
DCPH net income is -$194.9M
Is Deciphera Pharmaceuticals Growing As A Company?
-
What Is Deciphera Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.33% -
What Is Deciphera Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Deciphera Pharmaceuticals Stock Price Performance
-
Did Deciphera Pharmaceuticals Stock Go Up Last Month?
Deciphera Pharmaceuticals share price went down by -1.15% last month -
Did DCPH's Share Price Rise Over The Last Year?
DCPH share price rose by 1.81% over the past 1 year
What Is Deciphera Pharmaceuticals 52-Week High & Low?
-
What Is Deciphera Pharmaceuticals’s 52-Week High Share Price?
Deciphera Pharmaceuticals has traded as high as $17.73 over the past 52 weeks -
What Is Deciphera Pharmaceuticals’s 52-Week Low Share Price?
Deciphera Pharmaceuticals has traded as low as $9.90 over the past 52 weeks
Deciphera Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Deciphera Pharmaceuticals?
-
How Much Debt Does Deciphera Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Deciphera Pharmaceuticals Have?
Cash and short term investments quarterly total is $306.2M -
What Is Deciphera Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.36
Is Deciphera Pharmaceuticals Cash Flow Positive?
-
What Is DCPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$146.7M -
What Is Deciphera Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $152M -
What Is Deciphera Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $12.5M
Deciphera Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
DCPH return on invested capital is -50.8% -
What Is Deciphera Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -39.24% -
What Is DCPH Return On Equity?
ROE is a measure of profitability and is -50.8%
Deciphera Pharmaceuticals Earnings Date & Stock Price
-
What Is Deciphera Pharmaceuticals's Stock Price Today?
A single share of DCPH can be purchased today for 14.65 -
What Is Deciphera Pharmaceuticals’s Stock Symbol?
Deciphera Pharmaceuticals trades on the nasdaq under the ticker symbol: DCPH -
When Is Deciphera Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Deciphera Pharmaceuticals is scheduled on May 3, 2024 -
When Is DCPH's next ex-dividend date?
Deciphera Pharmaceuticals's next ex-dividend date is June 16, 2020 -
How To Buy Deciphera Pharmaceuticals Stock?
You can buy Deciphera Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Deciphera Pharmaceuticals Competitors
-
Who Are Deciphera Pharmaceuticals's Competitors?
Below is a list of companies who compete with Deciphera Pharmaceuticals or are related in some way:
Deciphera Pharmaceuticals Dividend Yield
Data Unavailable
Deciphera Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 7.95% |
Revenue: | 32.88% | 3.19% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 24.20 |
Upside from Last Price: | 65.19% |